Option Care Health (NASDAQ:OPCH) Upgraded to “Buy” at Wall Street Zen

Option Care Health (NASDAQ:OPCH) was upgraded by equities research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Saturday.

A number of other research analysts have also recently weighed in on OPCH. Stephens raised Option Care Health to a “strong-buy” rating in a research report on Thursday, December 11th. Cowen started coverage on shares of Option Care Health in a research note on Thursday, October 2nd. They set a “hold” rating on the stock. TD Cowen dropped their price target on shares of Option Care Health from $30.00 to $27.00 and set a “hold” rating for the company in a research report on Monday, November 3rd. JMP Securities set a $36.00 price objective on shares of Option Care Health in a research note on Friday, October 31st. Finally, Deutsche Bank Aktiengesellschaft raised their price objective on shares of Option Care Health from $31.00 to $36.00 and gave the company a “buy” rating in a research report on Tuesday, December 9th. One analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $36.27.

Option Care Health Trading Down 0.6%

NASDAQ:OPCH opened at $31.78 on Friday. Option Care Health has a one year low of $23.68 and a one year high of $35.53. The business has a fifty day moving average price of $30.72 and a 200-day moving average price of $29.44. The firm has a market capitalization of $5.04 billion, a price-to-earnings ratio of 25.22, a price-to-earnings-growth ratio of 1.99 and a beta of 0.80. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.56 and a quick ratio of 1.05.

Insider Buying and Selling at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. bought 38,000 shares of the company’s stock in a transaction that occurred on Monday, November 3rd. The stock was purchased at an average price of $25.98 per share, for a total transaction of $987,240.00. Following the completion of the transaction, the director owned 413,390 shares in the company, valued at $10,739,872.20. The trade was a 10.12% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. Corporate insiders own 0.64% of the company’s stock.

Institutional Trading of Option Care Health

Several hedge funds have recently bought and sold shares of the stock. Strs Ohio bought a new position in Option Care Health during the first quarter valued at approximately $636,000. Boston Partners raised its holdings in shares of Option Care Health by 34.8% during the 2nd quarter. Boston Partners now owns 952,299 shares of the company’s stock worth $30,311,000 after acquiring an additional 245,990 shares in the last quarter. Swedbank AB bought a new position in shares of Option Care Health during the 3rd quarter valued at approximately $49,455,000. Fort Washington Investment Advisors Inc. OH boosted its position in shares of Option Care Health by 11.8% during the 2nd quarter. Fort Washington Investment Advisors Inc. OH now owns 883,404 shares of the company’s stock valued at $28,693,000 after acquiring an additional 92,984 shares during the last quarter. Finally, Aristides Capital LLC purchased a new position in shares of Option Care Health in the second quarter valued at $249,000. Hedge funds and other institutional investors own 98.05% of the company’s stock.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.